Mendus AB (publ) (STO:IMMU)
6.51
-0.24 (-3.56%)
Jul 24, 2026, 5:29 PM CET
Mendus AB Revenue
Mendus AB had revenue of 6.61M SEK in the quarter ending March 31, 2026, with 393.28% growth. This brings the company's revenue in the last twelve months to 13.17M, up 265.51% year-over-year. In the year 2025, Mendus AB had annual revenue of 7.90M.
Revenue (ttm)
13.17M
Revenue Growth
+265.51%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
19
Market Cap
414.10M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.90M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 29.61M | 26.24M | 777.42% |
| Dec 31, 2022 | 3.38M | 3.34M | 10,787.10% |
| Dec 31, 2021 | 31.00K | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | 33.38M | 33.01M | 8,970.65% |
| Dec 31, 2018 | 368.00K | 150.00K | 68.81% |
| Dec 31, 2017 | 218.00K | - | - |
| Dec 31, 2016 | 0 | - | - |
| Jun 30, 2016 | - | - | - |
| Jun 30, 2015 | 160.00K | -400.00K | -71.43% |
| Jun 30, 2014 | 560.00K | 558.53K | 37,917.65% |
| Jun 30, 2013 | 1.47K | -137.53K | -98.94% |
| Jun 30, 2012 | 139.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cantargia AB | 317.21M |
| Sprint Bioscience AB | 153.28M |
| IRLAB Therapeutics AB | 92.46M |
| Xbrane Biopharma AB | 83.30M |
| Oncopeptides AB | 83.24M |
| Intervacc AB | 18.89M |
| Corline Biomedical AB | 10.67M |
| Xspray Pharma AB | 2.47M |
Mendus AB News
- 2 months ago - Mendus AB Earnings Call Transcript: Q1 2026 - Transcripts
- 2 months ago - Mendus AB Quarterly report: Q1 2026 - Filings
- 2 months ago - Mendus AB Slides: Q1 2026 - Filings
- 3 months ago - Mendus AB Slides: Corporate presentation - Filings
- 5 months ago - Mendus AB Earnings Call Transcript: Q4 2025 - Transcripts
- 5 months ago - Mendus AB Quarterly report: Q4 2025 - Filings
- 5 months ago - Mendus AB Slides: Q4 2025 - Filings
- 5 months ago - Mendus AB Annual report: Q4 2025 - Filings